001     134841
005     20240229105043.0
024 7 _ |a 10.3389/fimmu.2018.01114
|2 doi
024 7 _ |a WOS:000432827900001
|2 WOS
037 _ _ |a DKFZ-2018-00631
082 _ _ |a 610
100 1 _ |a Shemesh, Avishai
|b 0
245 _ _ |a NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death
260 _ _ |a Lausanne
|c 2018
|b Frontiers Media
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1529308114_16578
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 314 - Tumor immunology (POF3-314)
|0 G:(DE-HGF)POF3-314
|c POF3-314
|f POF III
|x 0
588 _ _ |a Dataset connected to Web of Science, Web of Science, , CrossRef
700 1 _ |a Kundu, Kiran
|b 1
700 1 _ |a Peleg, Refael
|b 2
700 1 _ |a Yossef, Rami
|b 3
700 1 _ |a Kaplanov, Irena
|b 4
700 1 _ |a Ghosh, Susmita
|b 5
700 1 _ |a Khrapunsky, Yana
|b 6
700 1 _ |a Gershoni-Yahalom, Orly
|b 7
700 1 _ |a Rabinski, Tatiana
|b 8
700 1 _ |a Cerwenka, Adelheid
|0 P:(DE-He78)d2b4dd8bdffe4aaa0f5e30e91587766f
|b 9
|u dkfz
700 1 _ |a Atlas, Roee
|b 10
700 1 _ |a Porgador, Angel
|b 11
773 _ _ |a 10.3389/fimmu.2018.01114
|g Vol. 9, p. 1114
|0 PERI:(DE-600)2606827-8
|p 1114
|t Frontiers in immunology
|v 9
|y 2018
|x 1664-3224
909 C O |o oai:inrepo02.dkfz.de:134841
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)d2b4dd8bdffe4aaa0f5e30e91587766f
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-314
|2 G:(DE-HGF)POF3-300
|v Tumor immunology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT IMMUNOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b FRONT IMMUNOL : 2015
920 1 _ |0 I:(DE-He78)D080-20160331
|k D080
|l Nachwuchsgruppe Angeborene Immunität
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D080-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21